The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
phenacetyl KKR-acid ID: ALA492694
PubChem CID: 44569041
Max Phase: Preclinical
Molecular Formula: C26H44N8O5
Molecular Weight: 548.69
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Phenacetyl Kkr-Acid | phenacetyl KKR-acid|CHEMBL492694
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)Cc1ccccc1)C(=O)O
Standard InChI: InChI=1S/C26H44N8O5/c27-14-6-4-11-19(32-22(35)17-18-9-2-1-3-10-18)23(36)33-20(12-5-7-15-28)24(37)34-21(25(38)39)13-8-16-31-26(29)30/h1-3,9-10,19-21H,4-8,11-17,27-28H2,(H,32,35)(H,33,36)(H,34,37)(H,38,39)(H4,29,30,31)/t19-,20-,21-/m0/s1
Standard InChI Key: XHVGUCXLWRVFJQ-ACRUOGEOSA-N
Molfile:
RDKit 2D
39 39 0 0 0 0 0 0 0 0999 V2000
2.0373 -11.3283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7532 -10.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4732 -12.1533 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4732 -11.3283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7532 -10.0866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4732 -9.6700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4732 -8.8450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1891 -8.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8962 -11.3232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6121 -10.0815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6121 -10.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8962 -12.1482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6121 -12.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6121 -13.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3321 -13.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4636 -7.6006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0391 -10.9047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7549 -12.1464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7549 -11.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0391 -10.0797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7549 -9.6631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7549 -8.8381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3214 -10.9183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6084 -11.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3185 -10.0933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1076 -10.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1075 -10.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8225 -9.6905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5365 -10.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5310 -10.9348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8153 -11.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1831 -7.5999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1832 -10.9081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3261 -14.6280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4693 -8.4255 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7506 -7.1822 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1865 -7.1822 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3261 -11.3197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4701 -10.9102 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
14 15 1 0
17 19 1 0
19 18 2 0
17 20 1 1
20 21 1 0
21 22 1 0
1 23 1 0
23 24 1 0
23 25 2 0
1 2 1 0
24 26 1 0
2 4 1 0
26 27 2 0
4 3 2 0
27 28 1 0
2 5 1 1
28 29 2 0
5 6 1 0
29 30 1 0
6 7 1 0
30 31 2 0
31 26 1 0
7 8 1 0
9 11 1 0
11 10 2 0
9 12 1 6
12 13 1 0
35 16 1 0
22 35 1 0
4 33 1 0
33 9 1 0
16 36 1 0
8 32 1 0
16 37 2 0
15 34 1 0
38 17 1 0
11 38 1 0
19 39 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 548.69Molecular Weight (Monoisotopic): 548.3435AlogP: -0.71#Rotatable Bonds: 20Polar Surface Area: 238.54Molecular Species: ZWITTERIONHBA: 7HBD: 9#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.74CX Basic pKa: 11.90CX LogP: -3.00CX LogD: -8.02Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.06Np Likeness Score: 0.10
References 1. Stoermer MJ, Chappell KJ, Liebscher S, Jensen CM, Gan CH, Gupta PK, Xu WJ, Young PR, Fairlie DP.. (2008) Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity., 51 (18): [PMID:18729351 ] [10.1021/jm800503y ] 2. Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM.. (2022) SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease., 57 [PMID:35123179 ] [10.1016/j.bmc.2022.116631 ]